Posted by Jack Davis on July 2nd, 2009 at 4:38 pm | Categorized as Docu-Drama, Geron | Tagged as GE Healthcare, Geron, Stem cells
Geron, the Menlo Park biopharmaceutical company that in January won approval from U.S. regulators to begin the first human test of embryonic stem cells by treating people who have spinal cord injuries, said today it had entered into an agreement with GE Healthcare, a division of General Electric based in the United Kingdom, giving it an exclusive license to Read the rest of this entry »
Leave a comment
Posted by Jack Davis on January 28th, 2009 at 6:02 pm | Categorized as Geron | Tagged as Drug development, Geron, Mergers and Acquisitions, Novacea, Transcept Pharmaceuticals
A day before Geron announced to the world last week that it had won approval from U.S. regulators to begin the first human test of embryonic stem cells by treating people who have spinal cord injuries, a member of its board told the company he was resigning.
John Walker, a member of the company’s Read the rest of this entry »
Leave a comment
Subscribe via RSS all feeds